Pharmaceutical stocks are making a comeback, says UBS' Michael Yee
Michael Yee, UBS global head of biotech research, joins 'Squawk Box' to discuss the quarterly earnings results of Merck and Eli Lilly, opportunities in pharma stocks, and more.
Michael Yee, UBS global head of biotech research, joins 'Squawk Box' to discuss the quarterly earnings results of Merck and Eli Lilly, opportunities in pharma stocks, and more.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
